# Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease

Study · id `cardio:ct-nct01418794` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01418794](<https://clinicaltrials.gov/study/NCT01418794>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01418794

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 606 participants.

## Technical summary

Registry record NCT01418794. Randomized; double masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2011-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 606 participants (planned count; ClinicalTrials.gov record NCT01418794, source copy `cardio:ctgov-nct01418794-2011-08-17`, retrieved 2026-10-31)
- Start date: 2010-10 (registry gives no type) (ClinicalTrials.gov record NCT01418794, source copy `cardio:ctgov-nct01418794-2011-08-17`, retrieved 2026-10-31)
- Primary completion: 2011-11 (anticipated) (ClinicalTrials.gov record NCT01418794, source copy `cardio:ctgov-nct01418794-2011-08-17`, retrieved 2026-10-31)
- Completion: Not reported
- Countries: China (ClinicalTrials.gov record NCT01418794, source copy `cardio:ctgov-nct01418794-2011-08-17`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01418794-2011-08-17`, retrieved 2026-10-31)

## The registry's words

- Brief title: Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease
- Condition: Acute Coronary Syndromes
- Intervention (Device): High dose rapamycin stent
- Intervention (Device): Low dose rapamycin stent
- Lead sponsor: Shenyang Northern Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: Shenyang Northern Hospital (`cardio:org-shenyang-northern-hospital`)

## Provenance

Content hash: 5ca8705f64fe94b86a8aeccb3b53f873717ac2b8a346b57f644af27f33cd2a28
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
